Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1973 1
1974 1
1975 1
1976 4
1977 1
1984 1
1985 1
1987 1
1995 1
1998 4
1999 1
2000 1
2001 2
2002 4
2003 3
2004 2
2005 7
2006 8
2007 7
2008 6
2009 6
2010 12
2011 5
2012 20
2013 11
2014 13
2015 23
2016 29
2017 22
2018 21
2019 20
2020 25
2021 20
2022 20
2023 28
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

295 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Szabo-Krausz
Page 1
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial.
Cortes J, Cescon DW, Rugo HS, Nowecki Z, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Holgado E, Iwata H, Masuda N, Otero MT, Gokmen E, Loi S, Guo Z, Zhao J, Aktan G, Karantza V, Schmid P; KEYNOTE-355 Investigators. Cortes J, et al. Lancet. 2020 Dec 5;396(10265):1817-1828. doi: 10.1016/S0140-6736(20)32531-9. Lancet. 2020. PMID: 33278935 Clinical Trial.
Vitamin D in the Prevention and Treatment of Diabetic Neuropathy.
Putz Z, Tordai D, Hajdú N, Vági OE, Kempler M, Békeffy M, Körei AE, Istenes I, Horváth V, Stoian AP, Rizzo M, Papanas N, Kempler P. Putz Z, et al. Clin Ther. 2022 May;44(5):813-823. doi: 10.1016/j.clinthera.2022.03.012. Epub 2022 Apr 12. Clin Ther. 2022. PMID: 35428527 Free article. Review.
Contemporary issues in breast pathology.
Quinn C, Schnitt SJ, Varga Z. Quinn C, et al. Virchows Arch. 2022 Jan;480(1):1-3. doi: 10.1007/s00428-022-03296-6. Epub 2022 Mar 30. Virchows Arch. 2022. PMID: 35353220 No abstract available.
[Endotheliitis in COVID-19].
Varga Z. Varga Z. Pathologe. 2020 Dec;41(Suppl 2):99-102. doi: 10.1007/s00292-020-00875-9. Pathologe. 2020. PMID: 33306138 Free PMC article. Review. German.
Cholecystokinin/opioid interactions.
Wiesenfeld-Hallin Z, de Araúja Lucas G, Alster P, Xu XJ, Hökfelt T. Wiesenfeld-Hallin Z, et al. Brain Res. 1999 Nov 27;848(1-2):78-89. doi: 10.1016/s0006-8993(99)01978-2. Brain Res. 1999. PMID: 10612699 Review.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
[Dermoscopy of inflammatory skin diseases].
Szebényi J, Légrádi M, Németh C, Joura MI, Gyulai R, Lengyel Z. Szebényi J, et al. Dermatologie (Heidelb). 2023 Apr;74(4):232-242. doi: 10.1007/s00105-023-05122-9. Epub 2023 Mar 10. Dermatologie (Heidelb). 2023. PMID: 36897374 Free PMC article. Review. German.
Diversity of breast cancers begins at imaging….
Kahán Z. Kahán Z. Eur J Radiol. 2022 Sep;154:110362. doi: 10.1016/j.ejrad.2022.110362. Epub 2022 May 20. Eur J Radiol. 2022. PMID: 35667298 No abstract available.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators. Bielack SS, et al. J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. J Clin Oncol. 2015. PMID: 26033801 Free PMC article. Clinical Trial.
295 results